Charlie Hospital Semarang PT (RSCH)

Currency in IDR
376.00
-6.00(-1.57%)
Closed·

RSCH Financial Summary

Key Ratios

P/E Ratio-74.67
Price/Book8.14
Debt / Equity104.96%
Return on Equity-10.35%
Dividend Yield0.00%
EBITDA5.41B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of IDR (except for per share items)

Earnings

Latest Release
Jul 31, 2025
EPS / Forecast
-1.82 / --
Revenue / Forecast
15.73B / --
EPS Revisions
Last 90 days

FAQ

What were Charlie Hospital Semarang PT's earnings for the latest quarter?

The Charlie Hospital Semarang PT EPS (TTM) is -5.60. Charlie Hospital Semarang PT reported sales of 15,731.15, net income of -4,813.62, and EPS of -1.82 for the latest quarter.

What was Charlie Hospital Semarang PT's net income for the latest quarter?

Charlie Hospital Semarang PT's net income for the latest quarter was -4,813.62.

How did Charlie Hospital Semarang PT's performance compare year-over-year in the latest quarter?

The company's revenue moved from 11,931.24 in the previous quarter to 15,731.15 in the latest quarter, and net income moved from -6,132.66 to -4,813.62 compared to the previous quarter.

What is Charlie Hospital Semarang PT's net profit margin on a TTM basis?

Charlie Hospital Semarang PT's trailing twelve months (TTM) net profit margin is -7.24%.

How does Charlie Hospital Semarang PT's debt to equity ratio compare to industry standards?

Charlie Hospital Semarang PT's total debt-to-equity ratio is 104.96%.

What is Charlie Hospital Semarang PT's return on investment on a TTM basis?

Charlie Hospital Semarang PT's trailing twelve months (TTM) return on investment (ROI) is -10.35%.

Did Charlie Hospital Semarang PT gain or lose cash last quarter?

In the latest quarter, Charlie Hospital Semarang PT's net change in cash was 3,637.98 million.

What were Charlie Hospital Semarang PT's total assets and liabilities in the latest quarter?

As of the latest quarter, Charlie Hospital Semarang PT reported total assets of 283,773.80 million and total liabilities of 10,089.05 million.

How has Charlie Hospital Semarang PT's total revenue grown this year?

Charlie Hospital Semarang PT's total revenue was 11,931.24 in the previous quarter and 15,731.15 in the latest quarter.

What is Charlie Hospital Semarang PT's gross margin on a TTM basis?

Charlie Hospital Semarang PT's trailing twelve months (TTM) gross margin is 17.02%.

What was Charlie Hospital Semarang PT's revenue per share for the latest quarter?

Charlie Hospital Semarang PT's revenue per share for the latest quarter was 409.21.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.